Genfit CEO: Don't count us out of NASH race
March 27, 2015 at 15:30 PM EDT
The CEO of biotech company Genfit told CNBC that the markets are overreacting to the results of its NASH study.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.